Prediction using serum glycosylated fibronectin of imminent pre-eclampsia in women with new-onset hypertension.

Sokratous, N; Bednorz, M; Wright, A; Nicolaides, K H; Kametas, N A

Sokratous, N; Bednorz, M; Wright, A; Nicolaides, K H; Kametas, N A.

Afiliação

Sokratous N; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Bednorz M; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Wright A; Institute of Health Research, University of Exeter, Exeter, UK.
Nicolaides KH; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Kametas NA; Fetal Medicine Research Institute, King's College Hospital, London, UK.

Ultrasound Obstet Gynecol ; 62(5): 653-659, 2023 11.

Article em En | MEDLINE | ID: mdl-37606310

Assuntos

Hipertensão; Pré-Eclâmpsia; Gravidez; Feminino; Humanos; Fator de Crescimento Placentário; Receptor 1 de Fatores de Crescimento do Endotélio Vascular; Idade Gestacional; Biomarcadores; Valor Preditivo dos Testes

Palavras-chave

angiogenic factor; antiangiogenic factor; glycosylated fibronectin; imminent pre-eclampsia; placental growth factor; soluble fms-like tyrosine kinase-1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Hipertensão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google